Skip to content

FCE Pharma 2026

T&B Pharma naFCE Pharma 2026

Specialists in GMP/GMP/GLP/BPAD, Qualifications and Validations and International Inspections (FDA/WHO/EMA)

Join us during FCE Pharma and discover how your company can adapt to the new regulatory requirements of ANVISA, PIC/S and ICH with more security, traceability and compliance.

ANVISA & PIC/S
GMP / BPF
WHO/FDA
+14 years
of regulatory excellence
Participation

T&B Pharma will be present na FCE Pharma

Our technical team will be available at Feira-FCE to talk about your needs and new ANVISA challenges, such as new requirements for compounding pharmacies (production of injectables), equipment qualification requirements for IFA (Annex 15), new revision of RDC 166 (Analytical Methods), and much more, come check it out!

Our focus will be on helping pharmaceutical, cosmetic, veterinary, food and medical device manufacturers reduce regulatory risks and increase operational compliance.

Data
01 - 3 June / 2026
TIME
11am to 7pm
Local
Sao Paulo Expo
Stand
i135
Featured Themes

End-to-end technical solutions

Knowledge applied throughout the life cycle of the pharmaceutical product.

Contamination and Sterility Control

  • CCS — Contamination Control Strategy
  • Media Fill
  • RABS and Insulators
  • Sterility guarantee
  • Environmental monitoring
  • Quality risk management
  • Qualification, Validation and QRM

  • Quality Risk Management (QRM)
  • Procedure life cycle
  • Control strategy
  • Risk-Based Qualifications
  • Analytical validation
  • AQbD
  • GMP Audits

  • Quality Audits – National and International Suppliers
  • GMP Internal Audits
  • Support for Action Plan – ANVISA Inspection
  • Support for Action Plan – FDA/WHO/EMA Inspection
  • New Regulatory Requirements

  • PIC/S Anexo 1
  • IN 35
  • RDC 166/2017
  • Cannabis Medicinal
  • Compounding Pharmacy
  • ANVISA audits
  • REGULATORY INSIGHTS

    Exclusive Technical Insights

    Talk to our experts during FCE Pharma and learn about the main trends, regulatory requirements and practical strategies to adapt to the new standards in the pharmaceutical industry.

    FEATURED THEME

    New Annex 1 PIC/S and CCS Strategy

    TECHNICAL DISCUSSION

    Media Fill, Sterility and Monitoring

    REGULATORY INSIGHTS

    RDC 166/2017, ICH Q2(R2) and AQbD

    SPECIALIZED CONSULTANCY

    Cleanrooms, GMP and Quality Management

    Fill in the data

    Schedule a conversation with our experts at FCE Pharma.

    Your data is secure and will only be used for technical/commercial contact with T&B Pharma.

    T&B Pharma Differentiators

    Technical authority on regulatory compliance

    GMP and GMP experts

    Experience in ANVISA audits

    Projects for the pharmaceutical industry

    Complete regulatory compliance

    Quality management and validation

    Multidisciplinary team

    Will participate in FCE Pharma 2026

    Schedule a conversation with our experts during the fair and discover how to accelerate your company's regulatory compliance.